1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Analysis & Statistics, November 2019

Cancer Analysis & Statistics, November 2019

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

1-30 of about 3300 reports

Ovarian Cancer: Opportunity Analysis and Forecasts to 2028

Ovarian Cancer: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • September 2019

Ovarian Cancer: Opportunity Analysis and Forecasts to 2028SummaryThe latest report “Ovarian Cancer: Opportunity Analysis and Forecasts to 2028” values the Ovarian Cancer market at $1.8bn in 2018 across ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States, World, Japan
Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • Industry report
  • August 2019

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028SummaryThe prostate cancer market will undergo a moderate increase at a compound annual growth rate (CAGR) of 3.3% from an estimated $9.3bn ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : United States, East Asia, Japan, China, World, North America
Cyramza

Cyramza

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCyramza (ramucirumab; Eli Lilly) is a fully human vascular endothelial growth factor receptor (VEGFR)-2-directed immunoglobulin G1 monoclonal antibody that binds to the extracellular domain ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Nexavar

Nexavar

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewNexavar (sorafenib; Bayer/Amgen) is an orally available, multi-targeted tyrosine kinase inhibitor that is directed against several targets, including CRAF, BRAF, RET, KIT, FMS-like tyrosine ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, Japan, European Union
Tecentriq

Tecentriq

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTecentriq (atezolizumab; Roche/Chugai) is a fully humanized monoclonal antibody that targets programmed death-ligand 1 (PD-L1). PD-L1 is expressed on the surface of antigen-presenting cells ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union
Opdivo

Opdivo

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewOpdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) is a fully human immunoglobulin G4 PD-1 immune checkpoint inhibitor that binds to the checkpoint receptor PD-1 expressed on activated ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union, Japan
Lenvima

Lenvima

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewLenvima (lenvatinib; Eisai/Merck and Co) is an orally available small molecule inhibitor of multiple tyrosine kinases, including vascular endothelial growth factor receptor (VEGFR), platelet-derived ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Keytruda

Keytruda

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewKeytruda (pembrolizumab; Merck and Co) is a humanized monoclonal antibody designed to inhibit the PD-1 co-inhibitory receptor. The interaction between PD-1 and its primary ligand, PD-L1, inhibits ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Stivarga

Stivarga

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewStivarga (regorafenib; Bayer/Amgen) is an orally available small molecule inhibitor that is currently approved for the treatment of previously treated hepatocellular carcinoma patients. It ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Cabometyx

Cabometyx

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCabometyx (cabozantinib; Exelixis/Ipsen/Takeda) is an orally available small molecule inhibitor which has been shown to suppress tumor growth and metastasis by inhibiting the activity of multiple ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Imfinzi

Imfinzi

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewImfinzi (durvalumab; AstraZeneca) is a human monoclonal antibody directed against programmed death-ligand 1 (PD-L1). The interaction between PD-L1 and its receptor, programmed death-1 (PD-1), ...

  • Industries : Pathology, Cancer
  • Countries : European Union, Japan, United States
Frontier Pharma - Small Cell Lung Cancer: Diverse First-in-Class Pipeline Shows Promise of Targeted Therapies to Treat Aggressive Disease

Frontier Pharma - Small Cell Lung Cancer: Diverse First-in-Class Pipeline Shows Promise of Targeted Therapies to Treat Aggressive Disease

  • $ 6995
  • Industry report
  • September 2019

Frontier Pharma - Small Cell Lung Cancer: Diverse First-in-Class Pipeline Shows Promise of Targeted Therapies to Treat Aggressive DiseaseSummaryInitially considered a curable disease due to substantial ...

  • Industries : Therapy, Medical Biotechnology, Cancer
  • Countries : United States
Hormone Receptor (HR)-positive/ Human Epidermal Receptor 2 (HER2)-negative Breast Cancer- Market Insights, Epidemiology and Market Forecast–2028

Hormone Receptor (HR)-positive/ Human Epidermal Receptor 2 (HER2)-negative Breast Cancer- Market Insights, Epidemiology and Market Forecast–2028

  • $ 6250
  • Industry report
  • September 2019

‘Hormone Receptor (HR)-positive/ Human Epidermal Receptor 2 (HER2)-negative Breast Cancer- Market Insights, Epidemiology and Market Forecast–2028 report delivers an in-depth understanding of the disease, ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : United States
Urothelial Carcinoma- Market Insights, Epidemiology and Market Forecast–2028

Urothelial Carcinoma- Market Insights, Epidemiology and Market Forecast–2028

  • $ 6250
  • Industry report
  • September 2019

‘Urothelial Carcinoma- Market Insights, Epidemiology and Market Forecast–2028’ report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology as well as the market ...

  • Industries : Cancer, Pathology
  • Countries : United States
Prostate Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Prostate Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • $ 5795
  • Industry report
  • September 2019

Prostate Cancer Therapeutics Market - Scope of the Study[206 Pages Report] the analyst (PMR) carried out a comprehensive analysis measuring the growth potential of the prostate cancer therapeutics market ...

  • Industries : Therapy
  • Countries : World, APAC
Anatomic Pathology Market by Product, Application ), End User - Global Forecast to 2024

Anatomic Pathology Market by Product, Application ), End User - Global Forecast to 2024

  • $ 5650
  • Industry report
  • October 2019

High incidence of cancer & other target diseases, availability of reimbursement, and the growing focus on personalized medicine are driving the overall growth of the anatomic pathology marketThe anatomic ...

  • Industries : Pathology, Healthcare
  • Countries : United States, North America
Companion Diagnostics Market by Product & Service, Technology, Indication, End-User, Region - Global Forecast to 2024

Companion Diagnostics Market by Product & Service, Technology, Indication, End-User, Region - Global Forecast to 2024

  • $ 5650
  • Industry report
  • September 2019

The companion diagnostics market is estimated to grow at a CAGR of 15.7%The companion diagnostics market is projected to reach 7.3 billion by 2024 from USD 3.5 billion in 2019, at a CAGR of 15.7%. The ...

  • Industries : Diagnostics, Healthcare
  • Countries : United States, North America
Intraoperative Radiation Therapy Market by Method, Products & Services, Application - Global Forecasts to 2024

Intraoperative Radiation Therapy Market by Method, Products & Services, Application - Global Forecasts to 2024

  • $ 5650
  • Industry report
  • September 2019

The intraoperative radiation therapy market is projected to grow at a CAGR of 7.0% during the forecast period.The global intraoperative radiation therapy market is projected to reach USD 68 million by ...

  • Industries : Health Services, Healthcare, Cancer
  • Countries : United States, North America
Enteral Feeding Devices Market by Type, Age Group, Application, End User - Global Forecast to 2024

Enteral Feeding Devices Market by Type, Age Group, Application, End User - Global Forecast to 2024

  • $ 5650
  • Industry report
  • August 2019

The Enteral feeding devices market is projected to grow at a CAGR of 6.7% during the forecast period (2019–2024).The enteral feeding devices market is projected to reach USD 4.1 billion by 2024 from ...

  • Industries : Pharmaceutical
  • Countries : United States, North America
Microtome Market by Product, Application, Technology, End User - Global Forecast to 2024

Microtome Market by Product, Application, Technology, End User - Global Forecast to 2024

  • $ 5650
  • Industry report
  • August 2019

High prevalence of cancer, growing demand for digital pathology, and increasing healthcare expenditure are expected to drive the overall growth of the microtomes marketThe microtomes market is expected ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics, Medical Supply, Healthcare, Medical Device
  • Countries : United States, North America
Global Kidney Cancer Drugs Industry

Global Kidney Cancer Drugs Industry

  • $ 5450
  • Industry report
  • October 2019

Kidney Cancer Drugs market worldwide is projected to grow by US$2 Billion, driven by a compounded growth of 5.1%. Targeted Therapy, one of the segments analyzed and sized in this study, displays the potential ...

  • Industries : Cancer
Global Pancreatic Cancer Drugs Industry

Global Pancreatic Cancer Drugs Industry

  • $ 5450
  • Industry report
  • October 2019

Pancreatic Cancer Drugs market worldwide is projected to grow by US$1.4 Billion, driven by a compounded growth of 7.7%. Endocrine, one of the segments analyzed and sized in this study, displays the potential ...

  • Industries : Cancer
  • Countries : APAC
Global Bladder Cancer Therapeutics Industry

Global Bladder Cancer Therapeutics Industry

  • $ 5450
  • Industry report
  • October 2019

Bladder Cancer Therapeutics market worldwide is projected to grow by US$89.9 Million, driven by a compounded growth of 4.8%. Transitional Cell Bladder Cancer, one of the segments analyzed and sized in ...

  • Industries : Therapy
  • Countries : World
Global Lung Cancer Therapeutics Industry

Global Lung Cancer Therapeutics Industry

  • $ 5450
  • Industry report
  • October 2019

Lung Cancer Therapeutics market worldwide is projected to grow by US$24 Billion, driven by a compounded growth of 12.9%. Non-Small-Cell Lung Cancer (NSCLC), one of the segments analyzed and sized in this ...

  • Industries : Therapy, Cancer, Pathology
  • Countries : APAC, World
Global Cancer Therapies Industry

Global Cancer Therapies Industry

  • $ 5450
  • Industry report
  • October 2019

Cancer Therapies market worldwide is projected to grow by US$93.1 Billion, driven by a compounded growth of 7.9%. Chemotherapy, one of the segments analyzed and sized in this study, displays the potential ...

  • Industries : Therapy
  • Countries : World
Global Lung Cancer Surgery Industry

Global Lung Cancer Surgery Industry

  • $ 5450
  • Industry report
  • October 2019

Lung Cancer Surgery market worldwide is projected to grow by US$13.2 Billion, driven by a compounded growth of 6.5%. Thoracotomy, one of the segments analyzed and sized in this study, displays the potential ...

  • Industries : Cancer, Pathology
  • Countries : APAC
Global Lymphoma Therapeutics Industry

Global Lymphoma Therapeutics Industry

  • $ 5450
  • Industry report
  • October 2019

Lymphoma Therapeutics market worldwide is projected to grow by US$9.3 Billion, driven by a compounded growth of 7.7%. Hodgkin Lymphoma (HL), one of the segments analyzed and sized in this study, displays ...

  • Industries : Cancer, Pathology
  • Countries : APAC, World
Global Liver Cancer Drugs Industry

Global Liver Cancer Drugs Industry

  • $ 5450
  • Industry report
  • October 2019

Liver Cancer Drugs market worldwide is projected to grow by US$1.5 Billion, driven by a compounded growth of 19.5%. Targeted Therapy, one of the segments analyzed and sized in this study, displays the ...

  • Industries : Cancer
  • Countries : APAC, World
Global Colorectal Cancer Therapeutics Industry

Global Colorectal Cancer Therapeutics Industry

  • $ 5450
  • Industry report
  • October 2019

Colorectal Cancer Therapeutics market worldwide is projected to grow by US$1.4 Billion, driven by a compounded growth of 2.1%. Chemotherapy, one of the segments analyzed and sized in this study, displays ...

  • Industries : Therapy
  • Countries : APAC, World
Global Breast Cancer Therapeutics Industry

Global Breast Cancer Therapeutics Industry

  • $ 5450
  • Industry report
  • October 2019

Breast Cancer Therapeutics market worldwide is projected to grow by US$13.1 Billion, driven by a compounded growth of 9%. Hormone Drugs, one of the segments analyzed and sized in this study, displays the ...

  • Industries : Therapy
  • Countries : APAC, World

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on